Year in Review: Multiple Myeloma
New drugs give physicians more options, but bad news for a prior accelerated approval
Source: medpagetoday.com
Stay updated with breaking news from Dangling Accelerated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New drugs give physicians more options, but bad news for a prior accelerated approval
Immunotherapy with checkpoint inhibitors has been a game changer for some cancer types, but development of this drug class has been uncoordinated and problematic, say FDA officials.